OrbiMed racks up $924 mln for second healthcare royalties fund

New York City-based OrbiMed has closed its second healthcare royalties and credit opportunities fund at $924 million.

2 February 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Fundraising Managers North America US Fundraising Briefs